Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

terminated133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Cell Saver Use in Bilateral Total Hip Arthroplasty (THA)

NCT01468129
unknownnot_applicable

Cost Effectiveness and Clinical Utility of Cell Saver Use for Two to Three Level Lumbar Fusions

NCT01453309
terminatedphase_3

Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory Response

NCT00159926

Clinical Trials (3)

Showing 3 of 3 trials
NCT01468129Not Applicable

Cell Saver Use in Bilateral Total Hip Arthroplasty (THA)

Unknown
NCT01453309Not Applicable

Cost Effectiveness and Clinical Utility of Cell Saver Use for Two to Three Level Lumbar Fusions

Unknown
NCT00159926Phase 3

Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory Response

Terminated

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3